Literature DB >> 33467423

Effects of p-Synephrine during Exercise: A Brief Narrative Review.

Carlos Ruiz-Moreno1, Juan Del Coso2, Verónica Giráldez-Costas1, Jaime González-García1, Jorge Gutiérrez-Hellín3.   

Abstract

The p-synephrine is the principal phytochemical found in bitter orange (Citrus aurantium). This substance is widely included in dietary supplements for weight loss/body fat reduction due to its potential benefits of increasing fat oxidation. For years, p-synephrine-containing dietary supplements have been marketed without proper knowledge of their true effectiveness to enhance fat utilization, especially when combined with exercise. However, the effects of p-synephrine on fat oxidation during exercise have been investigated in the last few years. The aim of the current discussion is to summarize the evidence on the effects of p-synephrine intake on fat oxidation and performance during exercise. Previous investigations have demonstrated that the acute intake of p-synephrine does not modify running sprint performance, jumping capacity, or aerobic capacity. However, the acute intake of p-synephrine, in a dose of 2-3 mg/kg of body mass, has been effective to enhance the rate of fat oxidation during incremental and continuous exercise. This effect has been observed in a range of exercise workloads between 30% and 80% of peak oxygen uptake (VO2peak). The p-synephrine has the ability to increase the maximal rate of fat oxidation during exercise of increasing intensity without affecting the workload at which maximal fat oxidation is obtained (Fatmax). The effect of p-synephrine on fat oxidation is normally accompanied by a concomitant reduction of carbohydrate utilization during exercise, without modifying the energy expended during exercise. The shifting in substrate oxidation is obtained without any effect on heart rate during exercise and the prevalence of adverse effects is negligible. Thus, the acute use of p-synephrine, or p-synephrine-containing products, might offer some benefits for those individuals seeking higher fat utilization during exercise at low to moderate intensities. However, more research is still necessary to determine if the effect of p-synephrine on fat oxidation during exercise is maintained with chronic ingestion, in order to ascertain the utility of this substance in conjunction with exercise programs to produce an effective body fat/weight loss reduction.

Entities:  

Keywords:  alkaloids; body composition; carbohydrate sparing; exercise; weight loss

Year:  2021        PMID: 33467423      PMCID: PMC7830131          DOI: 10.3390/nu13010233

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  38 in total

Review 1.  Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.

Authors:  S Haaz; K R Fontaine; G Cutter; N Limdi; S Perumean-Chaney; D B Allison
Journal:  Obes Rev       Date:  2006-02       Impact factor: 9.213

2.  Actions of p-synephrine on hepatic enzyme activities linked to carbohydrate metabolism and ATP levels in vivo and in the perfused rat liver.

Authors:  Marcos Rodrigues Maldonado; Lívia Bracht; Anacharis Babeto de Sá-Nakanishi; Rúbia Carvalho Gomes Corrêa; Jurandir Fernando Comar; Rosane Marina Peralta; Adelar Bracht
Journal:  Cell Biochem Funct       Date:  2017-12-21       Impact factor: 3.685

3.  p-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes.

Authors:  Li-Xia Guo; Gang Chen; Zhong-Yi Yin; Yong-Hong Zhang; Xu-Xu Zheng
Journal:  J Food Biochem       Date:  2019-09-04       Impact factor: 2.720

4.  Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.

Authors:  Christine A Haller; Minjing Duan; Peyton Jacob; Neal Benowitz
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

5.  High-performance liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara.

Authors:  Federica Pellati; Stefania Benvenuti; Michele Melegari
Journal:  Phytochem Anal       Date:  2004 Jul-Aug       Impact factor: 3.373

6.  p-Synephrine, the main protoalkaloid of Citrus aurantium, raises fat oxidation during exercise in elite cyclists.

Authors:  Jorge Gutiérrez-Hellín; Gabriel Baltazar-Martins; Iván Rodríguez; Beatriz Lara; Carlos Ruiz-Moreno; Millán Aguilar-Navarro; Juan Del Coso
Journal:  Eur J Sport Sci       Date:  2020-09-17       Impact factor: 4.050

7.  Caffeine increases whole-body fat oxidation during 1 h of cycling at Fatmax.

Authors:  Carlos Ruiz-Moreno; Jorge Gutiérrez-Hellín; Francisco J Amaro-Gahete; Jaime González-García; Verónica Giráldez-Costas; Víctor Pérez-García; Juan Del Coso
Journal:  Eur J Nutr       Date:  2020-10-06       Impact factor: 5.614

8.  p-Synephrine: a novel agonist for neuromedin U2 receptor.

Authors:  Xuxu Zheng; Lixia Guo; Daoqing Wang; Xiaohong Deng
Journal:  Biol Pharm Bull       Date:  2014-03-04       Impact factor: 2.233

Review 9.  p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties.

Authors:  Sidney J Stohs; Mohd Shara; Sidhartha D Ray
Journal:  Phytother Res       Date:  2020-02-26       Impact factor: 5.878

10.  Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats.

Authors:  N S Deshmukh; S J Stohs; C C Magar; A Kale; B Sowmya
Journal:  Toxicol Rep       Date:  2017-11-12
View more
  2 in total

1.  Multiple Direct Effects of the Dietary Protoalkaloid N-Methyltyramine in Human Adipocytes.

Authors:  Christian Carpéné; Pénélope Viana; Jessica Fontaine; Henrik Laurell; Jean-Louis Grolleau
Journal:  Nutrients       Date:  2022-07-29       Impact factor: 6.706

2.  The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine: A Systematic Review and Meta-Analysis.

Authors:  Dorottya Koncz; Barbara Tóth; Muh Akbar Bahar; Orsolya Roza; Dezső Csupor
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.